SeaCrest Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $380K | Sell |
757
-475
| -39% | -$228K | 0.04% | 359 |
|
|
2026
Q1 | $606K | Sell |
1,232
-8
| -0.6% | -$4.34K | 0.06% | 280 |
|
|
2025
Q4 | $765K | Sell |
1,240
-39
| -3% | -$22.1K | 0.08% | 234 |
|
|
2025
Q3 | $686K | Sell |
1,279
-241
| -16% | -$112K | 0.07% | 248 |
|
|
2025
Q2 | $616K | Sell |
1,520
-199
| -12% | -$83.2K | 0.07% | 266 |
|
|
2025
Q1 | $856K | Sell |
1,719
-24
| -1% | -$13K | 0.1% | 203 |
|
|
2024
Q4 | $907K | Buy |
1,743
+367
| +27% | +$202K | 0.1% | 199 |
|
|
2024
Q3 | $851K | Sell |
1,376
-191
| -12% | -$113K | 0.09% | 219 |
|
|
2024
Q2 | $867K | Sell |
1,567
-87
| -5% | -$49.8K | 0.1% | 202 |
|
|
2024
Q1 | $961K | Buy |
1,654
+40
| +2% | +$22.4K | 0.12% | 185 |
|
|
2023
Q4 | $857K | Sell |
1,614
-1
| -0.1% | -$484 | 0.11% | 201 |
|
|
2023
Q3 | $817K | Sell |
1,615
-10
| -0.6% | -$5.33K | 0.11% | 207 |
|
|
2023
Q2 | $848K | Sell |
1,625
-22
| -1% | -$11.9K | 0.11% | 205 |
|
|
2023
Q1 | $949K | Buy |
1,647
+273
| +20% | +$154K | 0.13% | 178 |
|
|
2022
Q4 | $757K | Buy |
1,374
+11
| +0.8% | +$5.83K | 0.11% | 220 |
|
|
2022
Q3 | $691K | Sell |
1,363
-19
| -1% | -$10.6K | 0.1% | 209 |
|
|
2022
Q2 | $751K | Sell |
1,382
-183
| -12% | -$101K | 0.09% | 217 |
|
|
2022
Q1 | $924K | Sell |
1,565
-61
| -4% | -$35K | 0.11% | 200 |
|
|
2021
Q4 | $1.08M | Buy |
1,626
+31
| +2% | +$19.4K | 0.12% | 175 |
|
|
2021
Q3 | $911K | Sell |
1,595
-28
| -2% | -$15.4K | 0.11% | 198 |
|
|
2021
Q2 | $819K | Buy |
1,623
+28
| +2% | +$13.2K | 0.1% | 219 |
|
|
2021
Q1 | $728K | Buy |
1,595
+24
| +2% | +$11.5K | 0.1% | 226 |
|
|
2020
Q4 | $732K | Sell |
1,571
-109
| -6% | -$51.1K | 0.1% | 218 |
|
|
2020
Q3 | $742K | Sell |
1,680
-24
| -1% | -$9.91K | 0.12% | 188 |
|
|
2020
Q2 | $617K | Sell |
1,704
-12
| -0.7% | -$4.02K | 0.11% | 220 |
|
|
2020
Q1 | $487K | Buy |
1,716
+92
| +6% | +$29K | 0.1% | 216 |
|
|
2019
Q4 | $528K | Buy |
1,624
+187
| +13% | +$56.7K | 0.09% | 268 |
|
|
2019
Q3 | $419K | Buy |
1,437
+105
| +8% | +$30.1K | 0.08% | 303 |
|
|
2019
Q2 | $391K | Buy |
1,332
+10
| +0.8% | +$2.75K | 0.08% | 310 |
|
|
2019
Q1 | $362K | Sell |
1,322
-170
| -11% | -$42.3K | 0.06% | 315 |
|
|
2018
Q4 | $334K | Sell |
1,492
-288
| -16% | -$67.6K | 0.07% | 298 |
|
|
2018
Q3 | $434K | Buy |
1,780
+609
| +52% | +$140K | 0.07% | 288 |
|
|
2018
Q2 | $243K | Buy |
1,171
+28
| +2% | +$5.94K | 0.04% | 426 |
|
|
2018
Q1 | $236K | Buy |
1,143
+118
| +12% | +$24.8K | 0.04% | 434 |
|
|
2017
Q4 | $195K | Buy |
+1,025
| New | +$196K | 0.04% | 503 |
|
Other funds holding TMO
SeaCrest Wealth Management's TMO Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 39% in Q2 2026, selling an estimated $228K and leaving 757 shares worth $380K. The position accounts for 0.04% of the portfolio, ranked #359.
SeaCrest Wealth Management first reported a position in TMO in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.08M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- SeaCrest Wealth Management held 757 shares of Thermo Fisher Scientific worth $380K as of Q2 2026.
- SeaCrest Wealth Management sold 475 Thermo Fisher Scientific shares in Q2 2026, an estimated $228K.
- Thermo Fisher Scientific made up 0.04% of SeaCrest Wealth Management's portfolio in Q2 2026, its #359 holding.
- SeaCrest Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Thermo Fisher Scientific position peaked at $1.08M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.